Team Sky principal Sir David Brailsford insists that Sir Bradley Wiggins' use of a banned drug ahead of major races including the 2012 Tour de France, which he won, was justified on medical grounds and that the rider was not seeking an unfair advantage over his rivals.
Medical records leaked by the Fancy Bears hackers who had accessed the World Anti-Doping Agency’s website revealed that ahead of the Tour de France in 2011 and 2012, as well as the 2013 Giro d’Italia, Wiggins secured a Therapeutic Use Exemption.
The certificates allowed him to receive intramuscular injections of triamcinolone as a result of an allergy to pollen and grass seeds. Wiggins appeared on BBC1’s Andrew Marr Show yesterday to insist he was not seeking a competitive advantage.
That view was endorsed today by his former boss at Team Sky, Brailsford, who told BBC Sport editor Dan Roan: "It was not being used to enhance performance.”
He went on: "I have known Bradley a long time and he is an asthma sufferer and he has struggled with allergies for as long as I have known him.
"I know that at the time there was a recommendation to see a specialist, he went to see a specialist and was then given permission by the authorities.
"I trust and believe in the integrity of that process," Brailsford added.
Simon joined road.cc as news editor in 2009 and is now the site’s community editor, acting as a link between the team producing the content and our readers. A law and languages graduate, published translator and former retail analyst, he has reported on issues as diverse as cycling-related court cases, anti-doping investigations, the latest developments in the bike industry and the sport’s biggest races. Now back in London full-time after 15 years living in Oxford and Cambridge, he loves cycling along the Thames but misses having his former riding buddy, Elodie the miniature schnauzer, in the basket in front of him.